Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance
Ashley A. Lloyd, Bernd Gludovatz, Christoph Riedel, Emma A. Luengo, Rehan Saiyed, Eric Marty, Dean G. Lorich, Joseph M. Lane, Robert O. Ritchie, Björn Busse, Eve Donnelly (2017). Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance. Proceedings of the National Academy of Sciences, 114(33), pp. 8722-8727, DOI: 10.1073/pnas.1704460114.
